It is a trading private limited company based in Kolkata, West Bengal, India, established in 2013.
2013 | Kolkata, West Bengal, India | ActiveRememax Pharmaceuticals Private Limited, a active private limited company, was established on 20 May 2013 in Kolkata, West Bengal, India. Engaging in specialty within the trading sector, it holds CIN: U51909WB2013PTC193479. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rajkumari Khemani (Director), Vinty Khemani (Director), Vineet Khemani (Director). Past directors included Navneet Khemani. It holds no open charges and ₹71.00 K settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 44A, Block B, 3Rd Floor, Rafi Ahmed Kidwai Road, Park Street, Kolkata, West Bengal, 700016.
U51909WB2013PTC193479
193479
20 May 2013
₹0.10 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Rememax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajkumari Khemani | Director | 21 May 2013 | Current |
| Vinty Khemani | Director | 29 Sep 2015 | Current |
| Vineet Khemani | Director | 20 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Aug 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rememax Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 92.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Rememax Pharmaceuticals had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹71,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2021 | Indian Overseas Bank | ₹0.07 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rememax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rememax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rememax Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rememax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge registered on 25 Jun 2021 via Charge ID 100461171 with Indian Overseas Bank was fully satisfied on 22 Aug 2024. was recorded as a recent event.
The activity Rememax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
Progress on A charge with Indian Overseas Bank amounted to Rs. 0.07 M with Charge ID 100461171 was registered on 25 Jun 2021. was documented.
Progress on Vinty Khemani was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 2 months . was documented.
The activity Rajkumari Khemani was appointed as a Director was appointed as a Director on 21 May 2013 & has been associated with this company since 12 years 6 months . was completed.
The CIN of Rememax Pharmaceuticals Private Limited is U51909WB2013PTC193479.
Rememax Pharmaceuticals Private Limited is headquartered at 44A, Block B, 3Rd Floor, Rafi Ahmed Kidwai Road, Park Street, Kolkata, West Bengal, 700016.
Rememax Pharmaceuticals Private Limited was incorporated on 20 May 2013.
The current directors of Rememax Pharmaceuticals Private Limited are
The primary industry of Rememax Pharmaceuticals Private Limited is Trading.
Rememax Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rememax Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rememax Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX